Hepatocellular Carcinoma Treatment Outcomes: The Influence Of Butyrate Producers Overview In a retrospective multi-center study involving 747 patients with advanced hepatocellular carcinoma (HCC) treated with a combination therapy of atezolizumab and bevacizumab, the influence of butyric acid-producing enterobacteria on treatment outcomes was investigated. Previous research has established a link between the gut
Tag: renal cell carcinoma
Remission of Renal Cell Carcinoma With Brain Metastases: A Case Study
Remission of Renal Cell Carcinoma With Brain Metastases: A Case Study Cases of complete remission of cancers with brain metastases are very rare. It’s often brought by tyrosine kinase inhibitor monotherapy in patients with metastatic renal cell carcinoma. For metastatic renal cell carcinoma (mRCC) patients, the case of brain metastasis has been
Renal Cell Carcinoma- Prognosis via Albumin Levels
Renal Cell Carcinoma- Prognosis via Albumin Levels Metastatic renal cell carcinoma (mRCC) - An Introduction Renal cell carcinoma (RCC) constitutes approximately 90% of all urologic malignancies. Approximately 30% of patients with RCC present with metastatic disease, and amongst those with localized disease, a substantial proportion will recur. Before 2005, immunotherapy with interleukin-2
Metastatic Renal Cell Carcinoma: A Meta‑Analysis Review of Therapy
Metastatic Renal Cell Carcinoma: A Meta‑Analysis Review of Therapy Background In 2021, there will be an estimated 76,080 new cases of kidney cancer in the US (48,780 in men and 27,300 in women) and about 13,780 patients (4,990 women, 8,790 men) will die from this disease. The most common form of kidney
